Enterprise Value
2.03B
Cash
816.2M
Avg Qtr Burn
-23.96M
Short % of Float
30.43%
Insider Ownership
11.54%
Institutional Own.
-
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
APG777 Details Atopic dermatitis | Phase 2 Data readout | |
APG777 Details Asthma | Phase 2 Initiation | |
APG808 Details Allergic diseases Type 2, Chronic obstructive pulmonary disease, Asthma | Phase 1 Data readout | |
APG990 Details Atopic dermatitis | Phase 1 Initiation |